Filing Details
- Accession Number:
- 0001209191-10-053843
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-09 09:22:54
- Reporting Period:
- 2010-11-05
- Filing Date:
- 2010-11-09
- Accepted Time:
- 2010-11-09 09:22:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1003642 | Impax Laboratories Inc | IPXL | Pharmaceutical Preparations (2834) | 650403311 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1336015 | Christopher Mengler | C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-11-05 | 7,460 | $19.32 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price reflecting the following individual transactions: 100 shares at $19.22; 700 shares at $19.24; 200 shares at $19.25; 1,600 shares at $19.27; 100 shares at $19.28; 310 shares at $19.29; 300 shares at $19.31; 100 shares at $19.33; 100 shares at $19.34; 1,200 shares at $19.35; 600 shares at $19.36; 700 shares at $19.37; 700 shares at $19.38; and 750 shares at $19.40.